(Circulation. 1997;96:3423-3429.)
© 1997 American Heart Association, Inc.
Articles |
Regional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
From Baker Medical Research Institute and the Alfred Baker Medical Unit, Alfred Hospital, Prahran, Victoria, Australia.
Correspondence to Prof Murray Esler, Baker Medical Research Institute, PO Box 348, Prahran 3181, Victoria, Australia.
Background Disturbed sympathetic nervous function may be of importance in obesity; sympathetic underactivity could contribute to deficient thermogenesis, positive energy balance, and weight gain, while in contrast, sympathetic nervous overactivity would predispose to the development of obesity-related hypertension. Global indices of sympathetic nervous system (SNS) function such as plasma or urinary norepinephrine (NE) have been unable to define SNS status in obesity. Since regional SNS activity can be altered in the absence of global changes, we investigated SNS activity in the heart, kidneys, and hepatomesenteric bed in healthy human subjects across a wide body mass index (BMI) range of between 19.6 and 35.5.
Methods and Results Whole-body and regional plasma NE kinetics using [3H]-labeled NE were assessed. Regional oxygen consumption was measured by combining arteriovenous differences in oxygen content and regional blood flow. Arterial plasma NE and whole-body plasma NE spillover were unrelated to BMI. With a BMI cutoff of 27, mean cardiac NE spillover was 46% lower in the obese subjects when compared with the lean subjects (P=.017). Renal NE spillover was significantly correlated with BMI (r=.668, P=.001), the mean value in the obese subjects being more than twice that in the lean subjects. Hepatomesenteric NE spillover was comparable in lean and obese subjects. Renal and hepatomesenteric oxygen consumption were both significantly higher in the obese subjects compared with lean subjects.
Conclusions Regional SNS activity is heterogeneous in the obese state. Important regional alterations, which may be clinically relevant, occur in the absence of changes in global indices of sympathetic nervous function. The enhanced renal NE spillover in obesity may have implications for the development of hypertension in this group, whereas the low cardiac sympathetic tone would be expected to be cardioprotective. Enhanced visceral oxygen consumption evident in the kidneys and hepatomesenteric circulation in proportion to body mass contributes to the greater resting oxygen consumption in obesity.
Key Words: obesity • norepinephrine • nervous system, autonomic • hypertension
This article has been cited by other articles:
 |
|
 |
|
  S. Michaels, G. A. Eppel, S. L. Burke, G. A. Head, J. Armitage, J. F. Carroll, S. C. Malpas, and R. G. Evans Altered responsiveness of the kidney to activation of the renal nerves in fat-fed rabbits Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1889 - R1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Hart, N. Charkoudian, B. G. Wallin, T. B. Curry, J. H. Eisenach, and M. J. Joyner Sex Differences in Sympathetic Neural-Hemodynamic Balance: Implications for Human Blood Pressure Regulation Hypertension, March 1, 2009; 53(3): 571 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Greenfield, J. W. Miller, J. M. Keogh, E. Henning, J. H. Satterwhite, G. S. Cameron, B. Astruc, J. P. Mayer, S. Brage, T. C. See, et al. Modulation of Blood Pressure by Central Melanocortinergic Pathways N. Engl. J. Med., January 1, 2009; 360(1): 44 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tank, K. Heusser, A. Diedrich, D. Hering, F. C. Luft, A. Busjahn, K. Narkiewicz, and J. Jordan Influences of Gender on the Interaction between Sympathetic Nerve Traffic and Central Adiposity J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4974 - 4978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Agapitov, M. L. d. G. Correia, C. A. Sinkey, and W. G. Haynes Dissociation Between Sympathetic Nerve Traffic and Sympathetically Mediated Vascular Tone in Normotensive Human Obesity Hypertension, October 1, 2008; 52(4): 687 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Carroll, A. C. Phillips, and G. Der Body Mass Index, Abdominal Adiposity, Obesity, and Cardiovascular Reactions to Psychological Stress in a Large Community Sample Psychosom Med, July 1, 2008; 70(6): 653 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujita Insulin resistance and salt-sensitive hypertension in metabolic syndrome Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3102 - 3107. [Full Text] [PDF]
|
|
|
|
|
|
E. Lambert, N. Straznicky, M. Schlaich, M. Esler, T. Dawood, E. Hotchkin, and G. Lambert Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension Hypertension, November 1, 2007; 50(5): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi Qualitative Assessment of Sympathetic Neural Drive in Cardiometabolic Disease: A New Challenge Hypertension, November 1, 2007; 50(5): 835 - 836. [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, F. Arenare, and G. Mancia Neurogenic Abnormalities in Masked Hypertension Hypertension, September 1, 2007; 50(3): 537 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kenchaiah, S. J. Pocock, D. Wang, P. V. Finn, L. A.M. Zornoff, H. Skali, M. A. Pfeffer, S. Yusuf, K. Swedberg, E. L. Michelson, et al. Body Mass Index and Prognosis in Patients With Chronic Heart Failure: Insights From the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program Circulation, August 7, 2007; 116(6): 627 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Lohmeier, T. M. Dwyer, E. D. Irwin, M. A. Rossing, and R. S. Kieval Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension Hypertension, June 1, 2007; 49(6): 1307 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Gentile, J. S. Orr, B. M. Davy, and K. P. Davy Modest weight gain is associated with sympathetic neural activation in nonobese humans Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1834 - R1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Stocker, R. Meador, and J. M. Adams Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats Hypertension, March 1, 2007; 49(3): 640 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi Adrenergic Overdrive as the Link Among Hypertension, Obesity, and Impaired Thermogenesis: Lights and Shadows Hypertension, January 1, 2007; 49(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
|
|
M. Esler, N. Straznicky, N. Eikelis, K. Masuo, G. Lambert, and E. Lambert Mechanisms of Sympathetic Activation in Obesity-Related Hypertension Hypertension, November 1, 2006; 48(5): 787 - 796. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Frisbee Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome J Appl Physiol, February 1, 2006; 100(2): 465 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esler and N. Eikelis Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol, January 1, 2006; 100(1): 11 - 12. [Full Text] [PDF]
|
|
|
|
|
|
N. E. Straznicky, E. A. Lambert, G. W. Lambert, K. Masuo, M. D. Esler, and P. J. Nestel Effects of Dietary Weight Loss on Sympathetic Activity and Cardiac Risk Factors Associated with the Metabolic Syndrome J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5998 - 6005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Eikelis and M. Esler The neurobiology of human obesity Exp Physiol, September 1, 2005; 90(5): 673 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G Haynes Role of leptin in obesity-related hypertension Exp Physiol, September 1, 2005; 90(5): 683 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, A. Facchini, F. Q. Trevano, R. Dell'Oro, F. Arenare, F. Tana, G. Bolla, A. Monzani, M. Robuschi, and G. Mancia Obstructive Sleep Apnea-Dependent and -Independent Adrenergic Activation in Obesity Hypertension, August 1, 2005; 46(2): 321 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rahmouni, D. A. Morgan, G. M. Morgan, A. L. Mark, and W. G. Haynes Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension Diabetes, July 1, 2005; 54(7): 2012 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Barrett and S. C. Malpas Problems, possibilities, and pitfalls in studying the arterial baroreflexes' influence over long-term control of blood pressure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R837 - R845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Engeli, J. Bohnke, K. Gorzelniak, J. Janke, P. Schling, M. Bader, F. C. Luft, and A. M. Sharma Weight Loss and the Renin-Angiotensin-Aldosterone System Hypertension, March 1, 2005; 45(3): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Schreihofer, C. D. Hair, and D. W. Stepp Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R253 - R261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark Obesity-Associated Hypertension: New Insights Into Mechanisms Hypertension, January 1, 2005; 45(1): 9 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Davy and J. E. Hall Obesity and hypertension: two epidemics or one? Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R803 - R813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Goodfriend and D. A. Calhoun Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy Hypertension, March 1, 2004; 43(3): 518 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rahmouni and W. G. Haynes Leptin and the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244. [Abstract] [Full Text]
|
|
|
|
|
|
R. Wolk, A. S.M. Shamsuzzaman, and V. K. Somers Obesity, Sleep Apnea, and Hypertension Hypertension, December 1, 2003; 42(6): 1067 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, G. Bolla, and G. Mancia Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients Hypertension, November 1, 2003; 42(5): 873 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Schlaich, D. M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M. D. Esler Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy Circulation, August 5, 2003; 108(5): 560 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Eikelis, M. Schlaich, A. Aggarwal, D. Kaye, and M. Esler Interactions Between Leptin and the Human Sympathetic Nervous System Hypertension, May 1, 2003; 41(5): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, R. Dell'Oro, C. Turri, L. Pasqualinotto, M. Colombo, and G. Mancia Participation of the Hypothalamus-Hypophysis Axis in the Sympathetic Activation of Human Obesity Hypertension, December 1, 2001; 38(6): 1316 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. H. Schiffelers, W. H. M. Saris, F. Boomsma, and M. A. van Baak {beta}1- and {beta}2-Adrenoceptor-Mediated Thermogenesis and Lipid Utilization in Obese and Lean Men J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2191 - 2199. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Akehi, H. Yoshimatsu, M. Kurokawa, T. Sakata, H. Eto, S. Ito, and J. Ono VLCD-Induced Weight Loss Improves Heart Rate Variability in Moderately Obese Japanese Experimental Biology and Medicine, May 1, 2001; 226(5): 440 - 445. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. M Sharma and S. Engeli The renin-angiotensin system in obesity hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S114 - S119. [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, R. Dell'Oro, C. Turri, G. B. Bolla, and G. Mancia Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension Hypertension, October 1, 2000; 36(4): 538 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Duncan, A. Kladis, G. L. Jennings, A. M. Dart, M. Esler, and D. J. Campbell Kinins in humans Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R897 - R904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Van De Borne, M. Hausberg, R. P. Hoffman, A. L. Mark, and E. A. Anderson Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R178 - R183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Lambert and I. H. Jonsdottir Influence of voluntary exercise on hypothalamic norepinephrine J Appl Physiol, September 1, 1998; 85(3): 962 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, M. Colombo, G. Bolla, B. M. Cattaneo, F. Cavagnini, and G. Mancia Body Weight Reduction, Sympathetic Nerve Traffic, and Arterial Baroreflex in Obese Normotensive Humans Circulation, May 26, 1998; 97(20): 2037 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, M. Colombo, G. Seravalle, D. Spaziani, and G. Mancia Dissociation Between Muscle and Skin Sympathetic Nerve Activity in Essential Hypertension, Obesity, and Congestive Heart Failure Hypertension, January 1, 1998; 31(1): 64 - 67. [Abstract] [Full Text] [PDF]
|
|